News

We're DCB Open Innovation Semifinalists!

diaVerge is working to develop the future of diabetes education through the intersection of personal connection, compassionate support, and technology.

This past August, the diaVerge team, lead by Lisa La Nasa and Pat Rowe, applied to the Diabetes Center Berne (DCB) International Open Innovation Challenge for our proprietary type 1 tech solution and we were thrilled to be announced as Top 20 Semifinalist in September.


DCB Open Innovation Challenge Description

About the DCB Challenge, from the Diabetes Center Berne website (Berne, Switzerland)


As semifinalists, we received mentorship from global leaders specializing in diabetes, tech, funding, and legal/regulatory considerations, many with T1D themselves.

The process of application, refining our proposal, and meeting with this group of mentors was an incredible experience that pushed us as a team to explore the 'why' and 'how' of optimal diabetes management, and what can be done to bring compassionate diabetes support & education to those with type 1 worldwide.
 

Although diaVerge didn’t make the final 3, we’re incredibly happy for the teams who did. There were many well-developed, deserving proposals, but the final 3 really stood out as exceptional.

It was an honor to be among the top 20 semifinalists, and we're grateful to DCB and all of our advisors and mentors who have helped us along the way. 

This is not over, though! We're applying to other think tanks, innovation challenges, and tech accelerator opportunities. The past three months have pushed us to see what is possible - and sorely needed within the T1D community - and we're just getting started!

Stay tuned for more.  

REAL LIFE LOW CARB Online Course Launch!

Want to improve your diabetes management? Curious about low carb methods for diabetes? Maybe you're eating LC but not achieving the blood sugar results you'd like. Join our “Real Life Low Carb” online course! You'll get a supportive community, tons of useful, real life information, along with videos, coaching, and an ebook workbook. Join us today!

Dismal Medtronic 670g Results for Pediatrics

The Medtronic 670g insulin pump system has been studied for pediatric patients with type 1 diabetes, although not yet approved by the FDA for that group. What are the pediatric results and how do they compare to adolescents and adults using the 670g in automatic mode? How does low carb compare to all of these results? 

Hey, Sugar! (How Sugar Has Taken Over The World)

Sugar is everywhere in the modern world, but do we really know the affect of sugar on our bodies or our minds? How much is too much sugar in the American diet? We discuss how the food industry is trying to deceive the consumer and how it's far too easy for most people to consume too much daily sugar.